[ad_1]
◀ Anchor ▶
Pfizer has requested the emergency use of the COVID-19 vaccine in Europe after the United States.
The governments of the European Union and the United States predict that vaccination will be available before the end of the year.
Reporter Kim Ji-man reports.
◀ Report ▶
The US pharmaceutical company Pfizer and the German Bioentech have requested the emergency use of the Corona 19 vaccine from the European Medicines Agency.
The vaccine was evaluated to have a 95% immunological effect as a result of a phase 3 clinical trial, the last stage before development.
The European Medicines Agency responded immediately that it would initiate a review of the quality, safety and efficacy of the vaccine, and if there are no problems, the evaluation will be completed at a special meeting scheduled for the 29th at the latest.
In addition, the Corona 19 vaccine from the US pharmaceutical company Modena, which was applied the day before, announced that it will hold a separate evaluation meeting no later than the 12th of next month to decide whether to end it.
In Europe, there is growing expectation that the vaccine will be vaccinated against Corona 19 starting this year.
[우르줄라 폰데어라이엔/유럽연합 집행위원장]“If everything goes according to plan, vaccinations will take place in the European Union before the end of December.”
Meanwhile, in the US, two companies have already started distributing vaccines.
The two companies filed for emergency use approval with the US Food and Drug Administration last month, so that if urgent use is approved, they can begin vaccinating immediately.
The US government predicts that 40 million doses could be administered within this month if urgent approval is granted.
This is MBC News.
MBC News awaits your report 24 hours a day.
▷ Telephone 02-784-4000
▷ Email [email protected]
▷ Report from KakaoTalk @mbc
